The Quattroflow QF20KSU single-use quaternary pump for biopharmaceutical processing reduces contamination risk and downtime.
Quattroflow QF1200-HT single- and multi-use pumps. Image courtesy of PSG.
Quattroflow, part of PSG, a Dover company, will introduce the new QF20KSU single-use pump at INTERPHEX in Booth No. 2253. The pump features replaceable polypropylene wetted pump chambers, which can be easily replaced as a complete unit between batches to eliminate sterilization, lower cross-product contamination risk, and reduce downtime. The QF20KSU features flow rates of 200–16,000 Lph (53–4227 gph), 51 mm (2 in.) connections, and autoclave and gamma irradiation capabilities.
Quattroflow QF1200-HT single- and multi-use pumps have a high turndown ratio for precise accuracy in controlling flow rates. Their compact design with integrated controller provides a plug-and-play solution for applications requiring precision flow control, quick batch changes, and a small footprint. The QF1200-HT offers flow rates of 6–1200 Lph (1.6–317 gph) and 19-mm (3/4 in.) connections.
Quattroflow pumps are used in a wide range of biopharmaceutical applications requiring gentle product handling, high containment, low pulsation, purity, and cleanability. Unlike peristaltic and lobe pumps, Quattroflow quaternary pumps use no moving parts to provide non-slip operation, which is optimal for transferring shear-sensitive products without damage, while virtually eliminating particle generation and heat degradation. The pumps are self-priming, provide safe dry-run operation, and allow for clean-in-place (CIP), sterilize-in-place (SIP), and autoclave capabilities.
Source: PSG
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.